SFM
NBP

Sphera Funds Management’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Sphera Funds Management’s Portfolio NBP Stock Details NBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-46,350
Closed -$3.89M – 132
2021
Q2 		$3.89M Sell
46,350
-8,612
-16% -$568K 0.26% 81
2021
Q1 		$2.66M Sell
54,962
-126,858
-70% -$6.88M 0.2% 98
2020
Q4 		$8.57M Hold
181,820
– – 0.76% 41
2020
Q3 		$8.55M Buy
+181,820
New +$5.99M 0.84% 31

Other funds holding NBP

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CC
Cederberg Capital London, United Kingdom $186M AUM 21.27% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ZAM
Zeal Asset Management Central, Hong Kong $39.4M AUM 38.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Sphera Funds Management's NBP Position: Q3 2021 in Review

Sphera Funds Management sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q3 2021, closing a stake of 46,350 shares — an estimated $3.89M sold.

Sphera Funds Management first reported a position in NBP in Q3 2020 and held it in 4 quarters. The position peaked at $8.57M in Q4 2020. 144 funds tracked by Wall St. Rank hold NBP as of Q3 2021.

  • Sphera Funds Management reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q3 2021 after selling out during the quarter.
  • Sphera Funds Management sold 46,350 NovaBridge Biosciences American Depositary Shares shares in Q3 2021, an estimated $3.89M.
  • Sphera Funds Management first reported a position in NovaBridge Biosciences American Depositary Shares in Q3 2020 and held it in 4 quarters.
  • Sphera Funds Management's NovaBridge Biosciences American Depositary Shares position peaked at $8.57M in Q4 2020.
  • 144 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q3 2021.

Based on Sphera Funds Management's 13F filing for Q3 2021, filed 15 Nov 2021.